LINC01641

Across TCGA pan-cancer cohorts, LINC01641 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated LINC01641 data layer compared with 1 for mutation status.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC01641 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01641 expression acts as an unfavorable survival marker, although some lineages such as GBM and COAD show a favorable association.

BRCA, KICH, and KIRC are the cancer types where LINC01641 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	III,IV	0.815	0.907	.004	49	view →
KICH	OS	Tertile	III,IV	0.178	0.848	<.001	30	view →
KIRC	OS	Tertile	All	0.742	0.827	.005	26	view →
ACC	DFS	Tertile	II,III,IV	0.140	0.591	.011	26	view →
LUAD	OS	Quartile	III,IV	0.271	0.638	.001	25	view →
LIHC	OS	Tertile	III,IV	0.323	0.639	.012	21	view →
MESO	OS	Tertile	IV	0.155	0.624	.004	19	view →
DLBC	DFS	Median	III,IV	0.275	0.879	.011	16	view →
GBM	OS	Quartile	All	0.315	0.215	.017	14	view →
COAD	DFS	Quartile	All	0.726	0.474	.023	12	view →
ESCA	DFS	Tertile	IV	0.692	0.242	.024	12	view →
OV	OS	Median	III,IV	0.269	0.356	.011	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

LINC01641–BRCA (DFS)

Open the BRCA breakdown →